Yanagisawa M, Takagi H, Takahashi H, Uehara M, Otsuka T, Yuasa K
Dig Dis Sci. 2009; 55(9):2651-8.
PMID: 20012485
DOI: 10.1007/s10620-009-1057-0.
Mackay I
Bull N Y Acad Med. 2009; 52(4):453-65.
PMID: 19312943
PMC: 1807167.
Kiernan T, Stevens F, Bourke M, McCarthy C
Ir J Med Sci. 1980; 149(2):63-5.
PMID: 7372450
DOI: 10.1007/BF02939113.
Whittingham S, Mathews J, Schanfield M, Tait B, Mackay I
Clin Exp Immunol. 1981; 43(1):80-6.
PMID: 7249397
PMC: 1537131.
Warnes T
J R Coll Physicians Lond. 1982; 16(1):23-32.
PMID: 7038110
PMC: 5377677.
Clinical, histologic, and immunopathologic features of primary biliary cirrhosis.
Popper H, Paronetto F
Springer Semin Immunopathol. 1980; 3(3):339-54.
PMID: 7022715
DOI: 10.1007/BF02054109.
Impaired glucose tolerance and growth hormone in chronic liver disease.
Riley W, McCann V
Gut. 1981; 22(4):301-5.
PMID: 7016688
PMC: 1419153.
DOI: 10.1136/gut.22.4.301.
Scleroderma, primary biliary cirrhosis, and Sjögren's syndrome after cosmetic breast augmentation with silicone injection: a case report of possible human adjuvant disease.
Okano Y, Nishikai M, Sato A
Ann Rheum Dis. 1984; 43(3):520-2.
PMID: 6742917
PMC: 1001386.
DOI: 10.1136/ard.43.3.520.
Primary biliary cirrhosis: geographical clustering and symptomatic onset seasonality.
Hamlyn A, Macklon A, James O
Gut. 1983; 24(10):940-5.
PMID: 6618273
PMC: 1420133.
DOI: 10.1136/gut.24.10.940.
HLA-DR antigens in primary biliary cirrhosis: lack of association.
Bassendine M, Dewar P, James O
Gut. 1985; 26(6):625-8.
PMID: 3859460
PMC: 1432751.
DOI: 10.1136/gut.26.6.625.
Histocompatibility and liver transplant outcome. Does HLA exert a dualistic effect?.
Markus B, Duquesnoy R, Gordon R, Fung J, Vanek M, Klintmalm G
Transplantation. 1988; 46(3):372-7.
PMID: 3047927
PMC: 2956422.
Immunological aspects of liver disease.
Eddleston A, Donaldson P, Hegarty J, Reed B
Gut. 1991; Suppl:S40-6.
PMID: 1916469
PMC: 1405230.
DOI: 10.1136/gut.32.suppl.s40.
Familial primary biliary cirrhosis associated with impaired concanavalin A-induced lymphocyte transformation in relatives. Two family studies.
Tsuji H, Murai K, Akagi K, Fujishima M
Dig Dis Sci. 1992; 37(3):353-60.
PMID: 1735358
DOI: 10.1007/BF01307727.
Recent advances in the study of the epidemiology of hepatitis B.
SZMUNESS W
Am J Pathol. 1975; 81(3):629-50.
PMID: 1108668
PMC: 2032336.
Hepatitis B antigen (HBAg) infection in a hemodialysis unit. I. HL-A8 and immune response to HBAg.
Sengar D, McLeish W, Sutherland M, Couture R, Rashid A
Can Med Assoc J. 1975; 112(8):968, 971.
PMID: 1093659
PMC: 1956047.
[Histocompatibility-(HLA) antigens in patients with HBsAg positive and negative hepatitis and healthy carriers of HBsAg and anti-HBs. (author's transl)].
Freudenberg J, Meyer zum Buschefelde K, Arnold W, Berger J, WEILLER H, Knolle J
Klin Wochenschr. 1976; 54(12):579-83.
PMID: 940293
DOI: 10.1007/BF01619573.
Active chronic hepatitis. Part I.
FULTON T, McCann V
Ulster Med J. 1976; 45(1):84-98.
PMID: 936363
PMC: 2385564.
Changing pattern of alcoholic liver disease in Great Britain: relation to sex and signs of autoimmunity.
Krasner N, Davis M, Portmann B, Williams R
Br Med J. 1977; 1(6075):1497-1500.
PMID: 871631
PMC: 1607282.
DOI: 10.1136/bmj.1.6075.1497.
Rheumatic disorders in primary biliary cirrhosis.
Clarke A, Galbraith R, HAMILTON E, Williams R
Ann Rheum Dis. 1978; 37(1):42-7.
PMID: 305233
PMC: 1000187.
DOI: 10.1136/ard.37.1.42.
Genetic analysis of patients with chronic active hepatitis.
PAGE A, Sharp H, Greenberg L, Yunis E
J Clin Invest. 1975; 56(3):530-5.
PMID: 125763
PMC: 301899.
DOI: 10.1172/JCI108121.